Integrative bioinformatics and machine learning identify iron metabolism genes MAP4, GPT, and HIRIP3 as diagnostic biomarkers and therapeutic targets in Alzheimer’s disease. This evidence concerns the gene GPT and early-onset autosomal dominant Alzheimer disease.